世界の生物製剤受託機関（CDMO）市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3906 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、生物製剤受託機関（CDMO）の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤受託開発サービス、生物製剤受託製造サービス）、用途別市場規模（大型製薬会社、小型製薬会社、ジェネリック製薬会社、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・生物製剤受託機関（CDMO）の市場動向 ・企業の競争状況、市場シェア ・生物製剤受託機関（CDMO）の種類別市場規模と予測2016-2027（生物製剤受託開発サービス、生物製剤受託製造サービス） ・生物製剤受託機関（CDMO）の用途別市場規模と予測2016-2027（大型製薬会社、小型製薬会社、ジェネリック製薬会社、その他） ・生物製剤受託機関（CDMO）の北米市場規模2016-2027（アメリカ、カナダ） ・生物製剤受託機関（CDMO）の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・生物製剤受託機関（CDMO）のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・生物製剤受託機関（CDMO）の中南米市場規模2016-2027（メキシコ、ブラジル） ・生物製剤受託機関（CDMO）の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Lonza、Hansen、Boehringer Ingelheim BioXcellence、Thermo Fisher Scientific、Samsung BioLogics、AGC Biologics、Catalent、Wuxi Biologics） ・結論

In this emerging in the form of cooperation, biological medicine industry further extended to the biological agents in the form of outsourcing cooperation contract development and manufacturing organization (CDMO) mode, the CDMO from preclinical studies and clinical trials to commercial production stage and the enterprise research and development, procurement, production, such as depth of the whole supply chain system docking, provide enterprises with innovative technology research and development and large-scale production services, in the higher value-added technology output instead of the pure output capacity.

Market Analysis and Insights: Global Biologics Contract Development and Manufacturing Organization(CDMO) Market
The global Biologics Contract Development and Manufacturing Organization(CDMO) market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Biologics Contract Development and Manufacturing Organization(CDMO) market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Biologics Contract Development and Manufacturing Organization(CDMO) market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Biologics Contract Development and Manufacturing Organization(CDMO) market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Biologics Contract Development and Manufacturing Organization(CDMO) market.

Global Biologics Contract Development and Manufacturing Organization(CDMO) Scope and Market Size
Biologics Contract Development and Manufacturing Organization(CDMO) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Biologics Contract Development and Manufacturing Organization(CDMO) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Biologics Contract Development Services
Biologics Contract Manufacturing Services

Segment by Application
Big Pharma
Small Pharma
Generic Pharma
Other

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Lonza
Hansen
Boehringer Ingelheim BioXcellence
Thermo Fisher Scientific
Samsung BioLogics
AGC Biologics
Catalent
Wuxi Biologics

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Biologics Contract Development Services
1.2.3 Biologics Contract Manufacturing Services
1.3 Market by Application
1.3.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Big Pharma
1.3.3 Small Pharma
1.3.4 Generic Pharma
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Perspective (2016-2027)
2.2 Biologics Contract Development and Manufacturing Organization(CDMO) Growth Trends by Regions
2.2.1 Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Biologics Contract Development and Manufacturing Organization(CDMO) Historic Market Share by Regions (2016-2021)
2.2.3 Biologics Contract Development and Manufacturing Organization(CDMO) Forecasted Market Size by Regions (2022-2027)
2.3 Biologics Contract Development and Manufacturing Organization(CDMO) Industry Dynamic
2.3.1 Biologics Contract Development and Manufacturing Organization(CDMO) Market Trends
2.3.2 Biologics Contract Development and Manufacturing Organization(CDMO) Market Drivers
2.3.3 Biologics Contract Development and Manufacturing Organization(CDMO) Market Challenges
2.3.4 Biologics Contract Development and Manufacturing Organization(CDMO) Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Biologics Contract Development and Manufacturing Organization(CDMO) Players by Revenue
3.1.1 Global Top Biologics Contract Development and Manufacturing Organization(CDMO) Players by Revenue (2016-2021)
3.1.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Players (2016-2021)
3.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biologics Contract Development and Manufacturing Organization(CDMO) Revenue
3.4 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Concentration Ratio
3.4.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics Contract Development and Manufacturing Organization(CDMO) Revenue in 2020
3.5 Biologics Contract Development and Manufacturing Organization(CDMO) Key Players Head office and Area Served
3.6 Key Players Biologics Contract Development and Manufacturing Organization(CDMO) Product Solution and Service
3.7 Date of Enter into Biologics Contract Development and Manufacturing Organization(CDMO) Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Biologics Contract Development and Manufacturing Organization(CDMO) Breakdown Data by Type
4.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Historic Market Size by Type (2016-2021)
4.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Forecasted Market Size by Type (2022-2027)

5 Biologics Contract Development and Manufacturing Organization(CDMO) Breakdown Data by Application
5.1 Global Biologics Contract Development and Manufacturing Organization(CDMO) Historic Market Size by Application (2016-2021)
5.2 Global Biologics Contract Development and Manufacturing Organization(CDMO) Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2016-2027)
6.2 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type
6.2.1 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021)
6.2.2 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2022-2027)
6.2.3 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2027)
6.3 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application
6.3.1 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2021)
6.3.2 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2022-2027)
6.3.3 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2027)
6.4 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country
6.4.1 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2016-2021)
6.4.2 North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2016-2027)
7.2 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type
7.2.1 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021)
7.2.2 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2022-2027)
7.2.3 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2027)
7.3 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application
7.3.1 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2021)
7.3.2 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2022-2027)
7.3.3 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2027)
7.4 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country
7.4.1 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2016-2021)
7.4.2 Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2016-2027)
8.2 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type
8.2.1 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2027)
8.3 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application
8.3.1 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2027)
8.4 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Region
8.4.1 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2016-2027)
9.2 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type
9.2.1 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021)
9.2.2 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2022-2027)
9.2.3 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2027)
9.3 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application
9.3.1 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2021)
9.3.2 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2022-2027)
9.3.3 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2027)
9.4 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country
9.4.1 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2016-2021)
9.4.2 Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (2016-2027)
10.2 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type
10.2.1 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2027)
10.3 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application
10.3.1 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2027)
10.4 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country
10.4.1 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.1.4 Lonza Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
11.1.5 Lonza Recent Development
11.2 Hansen
11.2.1 Hansen Company Details
11.2.2 Hansen Business Overview
11.2.3 Hansen Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.2.4 Hansen Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
11.2.5 Hansen Recent Development
11.3 Boehringer Ingelheim BioXcellence
11.3.1 Boehringer Ingelheim BioXcellence Company Details
11.3.2 Boehringer Ingelheim BioXcellence Business Overview
11.3.3 Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.3.4 Boehringer Ingelheim BioXcellence Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
11.3.5 Boehringer Ingelheim BioXcellence Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Details
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.4.4 Thermo Fisher Scientific Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Samsung BioLogics
11.5.1 Samsung BioLogics Company Details
11.5.2 Samsung BioLogics Business Overview
11.5.3 Samsung BioLogics Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.5.4 Samsung BioLogics Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
11.5.5 Samsung BioLogics Recent Development
11.6 AGC Biologics
11.6.1 AGC Biologics Company Details
11.6.2 AGC Biologics Business Overview
11.6.3 AGC Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.6.4 AGC Biologics Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
11.6.5 AGC Biologics Recent Development
11.7 Catalent
11.7.1 Catalent Company Details
11.7.2 Catalent Business Overview
11.7.3 Catalent Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.7.4 Catalent Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
11.7.5 Catalent Recent Development
11.8 Wuxi Biologics
11.8.1 Wuxi Biologics Company Details
11.8.2 Wuxi Biologics Business Overview
11.8.3 Wuxi Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Introduction
11.8.4 Wuxi Biologics Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
11.8.5 Wuxi Biologics Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Biologics Contract Development Services
Table 3. Key Players of Biologics Contract Manufacturing Services
Table 4. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Regions (2016-2021)
Table 8. Global Biologics Contract Development and Manufacturing Organization(CDMO) Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Regions (2022-2027)
Table 10. Biologics Contract Development and Manufacturing Organization(CDMO) Market Trends
Table 11. Biologics Contract Development and Manufacturing Organization(CDMO) Market Drivers
Table 12. Biologics Contract Development and Manufacturing Organization(CDMO) Market Challenges
Table 13. Biologics Contract Development and Manufacturing Organization(CDMO) Market Restraints
Table 14. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Players (2016-2021)
Table 16. Global Top Biologics Contract Development and Manufacturing Organization(CDMO) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) as of 2020)
Table 17. Ranking of Global Top Biologics Contract Development and Manufacturing Organization(CDMO) Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Biologics Contract Development and Manufacturing Organization(CDMO) Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biologics Contract Development and Manufacturing Organization(CDMO) Product Solution and Service
Table 21. Date of Enter into Biologics Contract Development and Manufacturing Organization(CDMO) Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Type (2016-2021)
Table 25. Global Biologics Contract Development and Manufacturing Organization(CDMO) Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Application (2016-2021)
Table 29. Global Biologics Contract Development and Manufacturing Organization(CDMO) Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size by Country (2022-2027) & (US$ Million)
Table 61. Lonza Company Details
Table 62. Lonza Business Overview
Table 63. Lonza Biologics Contract Development and Manufacturing Organization(CDMO) Product
Table 64. Lonza Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021) & (US$ Million)
Table 65. Lonza Recent Development
Table 66. Hansen Company Details
Table 67. Hansen Business Overview
Table 68. Hansen Biologics Contract Development and Manufacturing Organization(CDMO) Product
Table 69. Hansen Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021) & (US$ Million)
Table 70. Hansen Recent Development
Table 71. Boehringer Ingelheim BioXcellence Company Details
Table 72. Boehringer Ingelheim BioXcellence Business Overview
Table 73. Boehringer Ingelheim BioXcellence Biologics Contract Development and Manufacturing Organization(CDMO) Product
Table 74. Boehringer Ingelheim BioXcellence Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021) & (US$ Million)
Table 75. Boehringer Ingelheim BioXcellence Recent Development
Table 76. Thermo Fisher Scientific Company Details
Table 77. Thermo Fisher Scientific Business Overview
Table 78. Thermo Fisher Scientific Biologics Contract Development and Manufacturing Organization(CDMO) Product
Table 79. Thermo Fisher Scientific Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021) & (US$ Million)
Table 80. Thermo Fisher Scientific Recent Development
Table 81. Samsung BioLogics Company Details
Table 82. Samsung BioLogics Business Overview
Table 83. Samsung BioLogics Biologics Contract Development and Manufacturing Organization(CDMO) Product
Table 84. Samsung BioLogics Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021) & (US$ Million)
Table 85. Samsung BioLogics Recent Development
Table 86. AGC Biologics Company Details
Table 87. AGC Biologics Business Overview
Table 88. AGC Biologics Biologics Contract Development and Manufacturing Organization(CDMO) Product
Table 89. AGC Biologics Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021) & (US$ Million)
Table 90. AGC Biologics Recent Development
Table 91. Catalent Company Details
Table 92. Catalent Business Overview
Table 93. Catalent Biologics Contract Development and Manufacturing Organization(CDMO) Product
Table 94. Catalent Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021) & (US$ Million)
Table 95. Catalent Recent Development
Table 96. Wuxi Biologics Company Details
Table 97. Wuxi Biologics Business Overview
Table 98. Wuxi Biologics Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021) & (US$ Million)
Table 99. Wuxi Biologics Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Type: 2020 VS 2027
Figure 2. Biologics Contract Development Services Features
Figure 3. Biologics Contract Manufacturing Services Features
Figure 4. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Application: 2020 VS 2027
Figure 5. Big Pharma Case Studies
Figure 6. Small Pharma Case Studies
Figure 7. Generic Pharma Case Studies
Figure 8. Other Case Studies
Figure 9. Biologics Contract Development and Manufacturing Organization(CDMO) Report Years Considered
Figure 10. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Regions: 2020 VS 2027
Figure 13. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Regions (2022-2027)
Figure 14. Global Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Players in 2020
Figure 15. Global Top Biologics Contract Development and Manufacturing Organization(CDMO) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biologics Contract Development and Manufacturing Organization(CDMO) as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Biologics Contract Development and Manufacturing Organization(CDMO) Revenue in 2020
Figure 17. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Type (2016-2021)
Figure 18. Global Biologics Contract Development and Manufacturing Organization(CDMO) Revenue Market Share by Type (2022-2027)
Figure 19. North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Type (2016-2027)
Figure 21. North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Application (2016-2027)
Figure 22. North America Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Country (2016-2027)
Figure 23. United States Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Type (2016-2027)
Figure 27. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Application (2016-2027)
Figure 28. Europe Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Country (2016-2027)
Figure 29. Germany Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Region (2016-2027)
Figure 39. China Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Type (2016-2027)
Figure 47. Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Application (2016-2027)
Figure 48. Latin America Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Country (2016-2027)
Figure 49. Mexico Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Biologics Contract Development and Manufacturing Organization(CDMO) Market Share by Country (2016-2027)
Figure 55. Turkey Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Biologics Contract Development and Manufacturing Organization(CDMO) Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Lonza Revenue Growth Rate in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
Figure 59. Hansen Revenue Growth Rate in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
Figure 60. Boehringer Ingelheim BioXcellence Revenue Growth Rate in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
Figure 62. Samsung BioLogics Revenue Growth Rate in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
Figure 63. AGC Biologics Revenue Growth Rate in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
Figure 64. Catalent Revenue Growth Rate in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
Figure 65. Wuxi Biologics Revenue Growth Rate in Biologics Contract Development and Manufacturing Organization(CDMO) Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---